Citation Impact
Citing Papers
IL-1 Blockade in Autoinflammatory Syndromes
2014
Interleukin-18 and IL-18 Binding Protein
2013
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
2015 Standout
Inflammation in cardiac injury, repair and regeneration
2015
The NLRP3 inflammasome in acute myocardial infarction
2017
Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages
2013
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
2013
Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure
2014
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
2017
Treating Life-Threatening Myocarditis by Blocking Interleukin-1*
2016
Interleukin-1β Blockade Improves Left Ventricular Systolic/Diastolic Function and Restores Contractility Reserve in Severe Ischemic Cardiomyopathy in the Mouse
2014
Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges
2015
Targeting Interleukin-1 in Heart Failure and Inflammatory Heart Disease
2014
Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
2013
Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
2014
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside
2018
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
2014
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Inflammatory processes in cardiovascular disease: a route to targeted therapies
2016
Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease
2018
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
2014
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes
2019
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
2014
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
2017 Standout
Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
2017
Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability
2014
Overview of the IL ‐1 family in innate inflammation and acquired immunity
2017
Interleukin-1 blockade in cardiovascular diseases: a clinical update
2018
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction
2015
Cytokine Storm
2020 Standout
Targeting Interleukin-1 in Heart Disease
2013
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction
2018
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
2015
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
2018
Interleukin-1 blockade for the treatment of pericarditis
2017
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
From C-Reactive Protein to Interleukin-6 to Interleukin-1
2016
Innate Immunity and the Failing Heart
2015
Works of George Mueller being referenced
Leukocyte Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction Treated with Anakinra
2014
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
2013
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
2014